Elevation of Donor-derived Cell-free DNA Before Biopsy-proven Rejection in Kidney Transplant
Jonathan S. Bromberg(University of Maryland, Baltimore), Suphamai Bunnapradist(University of California, Los Angeles), Sanjiv Anand(Intermountain Healthcare), Sangeeta Bhorade(University of Chicago), Navchetan Kaur(Natera (United States)), Michelle S. Bloom(VA Palo Alto Health Care System), Matthew Cooper(Medical College of Wisconsin), Hossein Tabriziani(Natera (United States)), Milagros Samaniego(Henry Ford Health System), Erik Stites(University of Colorado Anschutz Medical Campus), Kyle Marshall(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Philippe Gauthier(Centre de Coopération Internationale en Recherche Agronomique pour le Développement), Adam Prewett(Natera (United States)), Zachary Demko(Natera (United States)), Madeleine Armer-Cabral(Natera (United States))
Cited by 50
Related Papers
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update
|American Journal of Kidney Diseases|2015|1.3k
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
|Kidney International|2020|724
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
|American Journal of Respiratory and Critical Care Medicine|2013|686
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|557
Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation
|Proceedings of the National Academy of Sciences|2009|342